Nasopharyngeal Cancer Recurrent
Oncology·MeSH: Nasopharyngeal Neoplasms
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| toripalimab | Coherus Oncology, Inc. (CHRS) |
Frequently asked questions
How many drugs are in development for Nasopharyngeal Cancer Recurrent?
BioSniper tracks 1 drug in development for Nasopharyngeal Cancer Recurrent across 1 company.
How many clinical trials target Nasopharyngeal Cancer Recurrent?
There are 1 clinical trial targeting Nasopharyngeal Cancer Recurrent tracked by BioSniper.
Deep-dive into Nasopharyngeal Cancer Recurrent
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis